✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals
Market Cap
₹712 Cr.
P/E
21.83
About
NGL Fine-Chem Ltd is a manufacturer of pharmaceuticals and intermediates for usage in veterinary and human health. We cater to various global companies to custom manufacture high quality pharmaceutica… Read more
NGL Fine-Chem Ltd is a manufacturer of pharmaceuticals and intermediates for usage in veterina… Read more
Low
957
52W Range
High
2824
  • NGL Fine-Chem
  • Hikal
  • Sequent Scientific
  • TJI Pharma - Small Cap

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

8 Yes

Positive for this company

2 Neutral

Neutral for this company

7 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Operational Metrics

    Select a Metric
    • Total reactor capacity (kL)
    • R&D as a % of Total Sales (%)
    Peer Comparison
    Corporate Actions
    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less
    FAQs on NGL Fine-Chem Ltd. Business

    NGL Fine-Chem Ltd specializes in manufacturing pharmaceuticals and intermediates for veterinary and human health, providing high-quality customizable solutions to global companies.

    NGL Fine-Chem major competitors are Hikal, Sequent Scientific, Nectar Lifesciences, Kopran, Shree Ganesh Remed., SMS Lifesciences, Everest Organics.
    Market Cap of NGL Fine-Chem is ₹712 Crs.
    While the median market cap of its peers are ₹932 Crs.

    NGL Fine-Chem seems to be financially stable compared to its competitors.
    The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

    Company Filing
    2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release
    Investor Presentation Feb Mar Jun Sep Dec Mar Jun Sep Dec Feb Mar May Jun Aug Sep Dec Mar Jun Sep Dec
    Conference Call Mar Sep Mar Sep Mar Jun Sep Jun Sep Dec Mar Sep Dec
    Conference Call SummaryCon Call Summary
    Discussions & Analysis
    Ideas Dashboard
    Timeline
    Watchlist
    Portfolio
    Alerts
    Research
    Stock Screener
    Market
    Raw Material